Viewing Study NCT06186921



Ignite Creation Date: 2024-05-06 @ 7:55 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06186921
Status: RECRUITING
Last Update Posted: 2024-01-02
First Post: 2023-12-17

Brief Title: Intraligamentary Injections and Post-endodontic Pain
Sponsor: Jamia Millia Islamia
Organization: Jamia Millia Islamia

Study Overview

Official Title: Effect of Different Intraligamentary Injections on the Post-endodontic Pain in Patients With Symptomatic Irreversible Pulpitis
Status: RECRUITING
Status Verified Date: 2023-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will aim to evaluate postoperative pain after intraligamentary injections of dexamethasone 4mgml diclofenac sodium 25mgml 05 bupivacaine and 2 lidocaine given to the patients with symptomatic irreversible pulpitis after completion of the first appointment Objectives 1 To evaluate postoperative pain in patients receiving intraligamentary injections of either dexamethasone 4mgml diclofenac sodium 25mgml 05 bupivacaine or 2 lidocaine 2 To compare the postoperative pain in different groups
Detailed Description: The patients will receive a primary Inferior alveolar nerve block injection using 18 mL of 2 lidocaine with 1 80 000 epinephrine using a direct Halsted approach The needle will be inserted until bony resistance is felt After reaching the target area aspiration will be performed and the solution will be deposited over 60 seconds After 10 minutes the patients will be asked about the lip numbness Patients without profound lip numbness will be excluded from the study since the block will be considered as missed A conventional access opening will be initiated after isolation with a rubber dam After endodontic instrumentation and placement of temporary restoration the patients shall receive intraligamentary injections of dexamethasone 4mgml diclofenac sodium 25mgml 05 bupivacaine and 2 lidocaine The patients will be randomly allocated to treatment groups with the help of an online random generator The presence of postoperative pain using Heft Parker visual analog pain scale will be assessed at 2 hours 6 hours 24 hours and 72 hours after treatment The pain score proforma shall be collected at the subsequent visit

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None